Novel crystal form of cefazolin sodium and preparation method thereof

A technology of cefazolin sodium and crystal form, which is applied in the field of new crystal form of cefazolin sodium and its preparation, can solve the problems of relatively high requirements for drying and storage conditions, irregular product appearance, easy dehydration or moisture absorption, etc. It can achieve the effects of drying and long-term storage, good thermal stability and good stability

Active Publication Date: 2015-04-22
SHENYANG SANJIU PHARMA
View PDF8 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] The above-mentioned patents and literature reports are mainly crystalline forms of cefazolin sodium containing crystal water. These crystalline forms are easy to dehydrate or absorb moisture under certain temperature and pressure and transform into each other, so the requirements for drying and storage conditions are relatively high. At the same time During the long-term storage process, the product quality may fluctuate or change due to the transformation of the crystal form
Another amorphous form of cefazolin sodium reported in the above-mentioned patent is the solid form with the highest thermodynamic energy, so it also has problems such as poor thermal stability and irregular appearance of the product.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel crystal form of cefazolin sodium and preparation method thereof
  • Novel crystal form of cefazolin sodium and preparation method thereof
  • Novel crystal form of cefazolin sodium and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] Add 30g of cefazolin sodium product into 100ml of N,N-dimethylacetamide to form a suspension of 0.3g / ml, keep the stirring speed at 200r / min, and raise the temperature of the suspension at a rate of 0.1°C / min to 30°C, stir at constant temperature for 0.5h, then programmatically cool down to 0°C at a rate of 1°C / min, and grow crystals at constant temperature for 0.5h, filter the obtained crystal slurry, and place the obtained wet crystal product at 20°C under vacuum After drying at 0.1Mpa for 20 hours, the purity of the obtained new crystalline form of cefazolin sodium is 99.6%, and the process yield is 90.0%. Its X-ray powder diffraction pattern is as figure 2 As shown, there are characteristic peaks at diffraction angles 2θ=5.2, 5.6, 10.6, 14.7, 15.5, 16.1, 19.8, 20.4, 22.4, 26.9, 28.6, and 29.6 degrees; its DSC analysis results are as follows image 3 As shown, there is an obvious endothermic peak at 381.5K, and its thermal stability is better, which is more conduci...

Embodiment 2

[0028] Add 30g of cefazolin sodium product into 60ml of N,N-dimethylformamide to form a 0.5g / ml suspension, keep the stirring speed at 400r / min, and heat the suspension to 35°C at a rate of 0.8°C / min. ℃, stirring at constant temperature for 1.5h, then cooling down to 15°C at a rate of 0.5°C / min, and growing crystals at 15°C for 2h, filtering the resulting suspension, and placing the obtained wet crystal product at 65°C under a vacuum of After drying at 0.09Mpa for 2 hours, the purity of the new crystalline form of cefazolin sodium obtained was 99.5%, and the process yield was 91.2%. The X-ray powder diffraction pattern of the new crystal form has characteristic peaks at diffraction angles 2θ=5.0, 5.4, 10.8, 14.6, 15.5, 16.1, 19.7, 20.5, 22.6, 26.9, 28.8, and 29.8 degrees; the new crystal form product is analyzed by DSC The results show that there is an endothermic peak at 379.2K, which has better thermal stability and is more conducive to drying and long-term storage; the appe...

Embodiment 3

[0030]Add 30 g of cefazolin sodium product into 50 ml of methanol to form a suspension of 0.6 g / ml, keep the stirring speed at 600 r / min, heat the suspension to 45 °C at a rate of 1 °C / min, stir at constant temperature for 8 h, and then Cool down to 20°C at a speed of 0.1°C / min, and grow crystals at 20°C for 1 hour at a constant temperature, filter the resulting suspension, and dry the obtained wet crystal product at 35°C and a vacuum of 0.1Mpa for 5 hours to obtain The purity of the new crystalline form of cefazolin sodium is 99.6%, and the process yield is 95%. The X-ray powder diffraction pattern of the new crystal form has characteristic peaks at diffraction angles 2θ=5.0, 5.7, 10.7, 14.9, 15.4, 16.0, 19.8, 20.2, 22.2, 26.9, 28.5, and 29.8 degrees; the new crystal form product is analyzed by DSC The results show that there is an endothermic peak at 380.1K, and its thermal stability is better, which is more conducive to drying and long-term storage; the appearance of the ne...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a novel crystal form of cefazolin sodium and a crystallization preparation method thereof. An X-ray powder diffraction pattern is used for defining at the characteristic peaks of a diffraction angle of 2-theta degrees and DSC. The preparation method comprises the following steps: adding a cefazolin sodium solid into a solvent to prepare a suspension of 0.3-0.7g / mL; heating the suspension to 30-45 DEG C under a stirring condition; stirring for 0.5-12 hours at a constant temperature; cooling to 0-20 DEG C, and growing a crystal at a constant temperature for 0.5-2 hours; then filtering to obtain crystal slurry; and drying the filter cake obtained by filtering to obtain a product of the novel crystal form of cefazolin sodium. The novel crystal form has a higher heat-absorption temperature, the product purity, color and shape do not change after the product is stored for 100 days under a normal-temperature and dry condition, and the crystal form has relatively good stability. Compared with already reported crystal forms, the short-bar shaped novel crystal form has the advantages of relatively high dissolving speed and relatively high fluidity and bulk density, and is easy for commercially industrial large-scale implementation.

Description

technical field [0001] The invention belongs to the technical field of medicine separation, and in particular relates to a new crystal form of cefazolin sodium and a preparation method thereof. Background technique [0002] Cefazolin sodium (cefazolin sodium), its chemical name is (6R,7R)-3-[[(5-methyl-1,3,4-thiadiazol-2-yl)sulfur]methyl]-7 -[(1H-tetrazol-1-yl)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid sodium salt. Molecular formula: C 14 h 13 N 8 NaO 4 S 3 , with a molecular weight of 476.50. The structural formula is shown in the figure below: [0003] [0004] Cefazolin sodium is a semi-synthetic cephalosporin antibiotic widely used clinically at present, and it is a broad-spectrum antibiotic. It has antibacterial activity against most Gram-positive and Gram-negative bacteria in vivo, but is ineffective against Pseudomonas aeruginosa; it has antibacterial activity against penicillinase-producing bacteria, Staphylococcus aureus in vit...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07D501/36C07D501/12
CPCC07D501/12C07D501/36
Inventor 郝红勋张娇杨战鏖侯宝红黄权华尹秋响王永莉苏军权谢闯鲍颖
Owner SHENYANG SANJIU PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products